CN103709147A - 甲磺酸氟马替尼晶型及其制备方法和用途 - Google Patents
甲磺酸氟马替尼晶型及其制备方法和用途 Download PDFInfo
- Publication number
- CN103709147A CN103709147A CN201210379385.8A CN201210379385A CN103709147A CN 103709147 A CN103709147 A CN 103709147A CN 201210379385 A CN201210379385 A CN 201210379385A CN 103709147 A CN103709147 A CN 103709147A
- Authority
- CN
- China
- Prior art keywords
- crystal
- methylsulfonic acid
- preparation
- acid fluorine
- fluorine imatinib
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210379385.8A CN103709147A (zh) | 2012-10-09 | 2012-10-09 | 甲磺酸氟马替尼晶型及其制备方法和用途 |
CN201380031403.6A CN104364248B (zh) | 2012-10-09 | 2013-09-23 | 甲磺酸氟马替尼晶型及其制备方法和用途 |
PCT/CN2013/083968 WO2014056396A1 (zh) | 2012-10-09 | 2013-09-23 | 甲磺酸氟马替尼晶型及其制备方法和用途 |
TW102135288A TWI603968B (zh) | 2012-10-09 | 2013-09-30 | 甲磺酸氟馬替尼晶型及其製備方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210379385.8A CN103709147A (zh) | 2012-10-09 | 2012-10-09 | 甲磺酸氟马替尼晶型及其制备方法和用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103709147A true CN103709147A (zh) | 2014-04-09 |
Family
ID=50402537
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210379385.8A Pending CN103709147A (zh) | 2012-10-09 | 2012-10-09 | 甲磺酸氟马替尼晶型及其制备方法和用途 |
CN201380031403.6A Active CN104364248B (zh) | 2012-10-09 | 2013-09-23 | 甲磺酸氟马替尼晶型及其制备方法和用途 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380031403.6A Active CN104364248B (zh) | 2012-10-09 | 2013-09-23 | 甲磺酸氟马替尼晶型及其制备方法和用途 |
Country Status (3)
Country | Link |
---|---|
CN (2) | CN103709147A (zh) |
TW (1) | TWI603968B (zh) |
WO (1) | WO2014056396A1 (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105198860A (zh) * | 2014-06-12 | 2015-12-30 | 江苏豪森药业股份有限公司 | 新的甲磺酸氟马替尼晶型及其制备方法和用途 |
CN105777714A (zh) * | 2016-03-11 | 2016-07-20 | 江苏豪森药业集团有限公司 | 氟马替尼的精制方法 |
CN107652269A (zh) * | 2016-07-26 | 2018-02-02 | 江苏豪森药业集团有限公司 | 甲磺酸氟马替尼中间体纯化方法 |
CN111505032A (zh) * | 2019-01-30 | 2020-08-07 | 昆药集团股份有限公司 | 一种双氢青蒿素片中双氢青蒿素晶型的检测方法 |
CN114259497A (zh) * | 2016-07-26 | 2022-04-01 | 江苏豪森药业集团有限公司 | 氨基嘧啶类化合物的药物组合物及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1939910A (zh) * | 2004-12-31 | 2007-04-04 | 孙飘扬 | 氨基嘧啶类化合物及其盐和其制备方法与药物用途 |
-
2012
- 2012-10-09 CN CN201210379385.8A patent/CN103709147A/zh active Pending
-
2013
- 2013-09-23 WO PCT/CN2013/083968 patent/WO2014056396A1/zh active Application Filing
- 2013-09-23 CN CN201380031403.6A patent/CN104364248B/zh active Active
- 2013-09-30 TW TW102135288A patent/TWI603968B/zh active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105198860A (zh) * | 2014-06-12 | 2015-12-30 | 江苏豪森药业股份有限公司 | 新的甲磺酸氟马替尼晶型及其制备方法和用途 |
CN105777714A (zh) * | 2016-03-11 | 2016-07-20 | 江苏豪森药业集团有限公司 | 氟马替尼的精制方法 |
CN105777714B (zh) * | 2016-03-11 | 2018-09-07 | 江苏豪森药业集团有限公司 | 氟马替尼的精制方法 |
CN107652269A (zh) * | 2016-07-26 | 2018-02-02 | 江苏豪森药业集团有限公司 | 甲磺酸氟马替尼中间体纯化方法 |
CN114259497A (zh) * | 2016-07-26 | 2022-04-01 | 江苏豪森药业集团有限公司 | 氨基嘧啶类化合物的药物组合物及其制备方法 |
CN111505032A (zh) * | 2019-01-30 | 2020-08-07 | 昆药集团股份有限公司 | 一种双氢青蒿素片中双氢青蒿素晶型的检测方法 |
CN111505032B (zh) * | 2019-01-30 | 2023-11-21 | 昆药集团股份有限公司 | 一种双氢青蒿素片中双氢青蒿素晶型的检测方法 |
Also Published As
Publication number | Publication date |
---|---|
TWI603968B (zh) | 2017-11-01 |
WO2014056396A1 (zh) | 2014-04-17 |
TW201414726A (zh) | 2014-04-16 |
CN104364248A (zh) | 2015-02-18 |
CN104364248B (zh) | 2016-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104364248B (zh) | 甲磺酸氟马替尼晶型及其制备方法和用途 | |
KR20120113285A (ko) | 다사티닙 다결정체 및 그의 제조방법과 약물 조성물 | |
EP3448851B1 (en) | Di-substituted pyrazole compounds for the treatment of diseases | |
CN106661015A (zh) | 达沙替尼盐 | |
BR112019005337A2 (pt) | terapia combinada | |
CA2914999A1 (en) | Stable crystal form of tipiracil hydrochloride and crystallization method for the same | |
Prakhar et al. | A comprehensive review on sustained release matrix tablets: a promising dosage form | |
CN106795159B (zh) | 一种周期素依赖性蛋白激酶抑制剂的结晶形式及其制备方法 | |
AU2021391453A1 (en) | Heteroaryl-acetylenes, pharmaceutical compositions thereof, and their therapeutic applications | |
CN105246877A (zh) | 具有二苄胺结构的嘧啶化合物的新形态 | |
CN103724339A (zh) | 二氢嘧啶衍生物的晶型 | |
CN111205290B (zh) | 一种jak激酶抑制剂的结晶形式及其制备方法 | |
CN105198860A (zh) | 新的甲磺酸氟马替尼晶型及其制备方法和用途 | |
CN103073617B (zh) | N(2)-l-丙氨酰-l-谷氨酰胺的化合物 | |
CN100364533C (zh) | 盐酸吡格列酮滴丸及其制备方法 | |
CN102816146A (zh) | 甲磺酸氟马替尼晶型a及其制备方法和用途 | |
CN102796078A (zh) | 一种泮托拉唑化合物、制备方法及其药物制剂 | |
CN103509007B (zh) | 甲磺酸氟马替尼晶型及其制备方法和用途 | |
CN104974139B (zh) | 甲磺酸氟马替尼新晶型及其制备方法和医药用途 | |
CN105646520A (zh) | 一种稳定的艾日布林化合物 | |
CN102816147B (zh) | 甲磺酸氟马替尼晶型b及其制备方法和用途 | |
CN102070605A (zh) | 甲磺酸伊马替尼多晶型物和药用组合物 | |
CN103509006A (zh) | 甲磺酸氟马替尼晶型及其制备方法和用途 | |
CN111803447B (zh) | 一种制备无定形药物的方法 | |
TWI811901B (zh) | 一種嘧啶甲醯胺類化合物及其應用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: 222006 Jiangsu province Lianyungang Kaitai Dapu Road Industrial Area Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: 222006 Jiangsu province Lianyungang Kaitai Dapu Road Industrial Area Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160321 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: 222006 Jiangsu province Lianyungang Kaitai Dapu Road Industrial Area Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140409 |
|
WD01 | Invention patent application deemed withdrawn after publication |